Cargando…
Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism?
Cancer stem-like cells (CSC) represent a subpopulation of tumor cells with peculiar functionalities that distinguish them from the bulk of tumor cells, most notably their tumor-initiating potential and drug resistance. Given these properties, it appears logical that CSCs have become an important tar...
Autores principales: | Marcucci, Fabrizio, Caserta, Carmelo Antonio, Romeo, Elisabetta, Rumio, Cristiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449442/ https://www.ncbi.nlm.nih.gov/pubmed/30984612 http://dx.doi.org/10.3389/fonc.2019.00167 |
Ejemplares similares
-
The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System
por: Romeo, Elisabetta, et al.
Publicado: (2019) -
Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal
por: Marcucci, Fabrizio, et al.
Publicado: (2016) -
The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells
por: Marcucci, Fabrizio, et al.
Publicado: (2017) -
ANTIBODY DRUG CONJUGATES (ADCS)
por: Terpos, E.
Publicado: (2023) -
How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress—Therapeutic Implications
por: Marcucci, Fabrizio, et al.
Publicado: (2018)